Male Tgfb3+/− mice at 4 months of age exhibit renal fibrosis, EMT and glomerular damage with foot process effacement in podocytes, and show albuminuria, loss of renal function, lipid accumulation, lipid metabolism deregulation, insulin resistance and mitochondrial dysfunction with oxidative stress. This evidence concerns the gene TGFB3 and renal fibrosis.